0

Journal Articles

in Alzheimer Disease
 61-80 of 448 Articles
Original Contributions |  November 01, 2011
Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
Adam S. Fleisher, MD; Kewei Chen, PhD; Xiaofen Liu, MS; et al.
Arch Neurol. 2011;68(11):1404-1411. doi:10.1001/archneurol.2011.150.
Editorials |  October 01, 2011
Treat Alzheimer Disease Before It Is Symptomatic
Roger N. Rosenberg, MD
Arch Neurol. 2011;68(10):1237-1238. doi:10.1001/archneurol.2011.135.
Original Contributions |  October 01, 2011
Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study
Chengjie Xiong, PhD; Catherine M. Roe, PhD; Virginia Buckles, PhD; et al.
Arch Neurol. 2011;68(10):1313-1319. doi:10.1001/archneurol.2011.208.
Correspondence |  September 01, 2011
Alois Alzheimer's Case, Auguste D., Did Not Carry the N141I Mutation in PSEN2 Characteristic of Alzheimer Disease in Volga Germans
Ulrich Müller, MD, PhD; Pia Winter, MLT; Manuel B. Graeber, MD, PhD, FRCPath
Arch Neurol. 2011;68(9):1210-1211. doi:10.1001/archneurol.2011.218.
Correspondence |  September 01, 2011
Alois Alzheimer's Case, Auguste D., Did Not Carry the N141I Mutation in PSEN2 Characteristic of Alzheimer Disease in Volga Germans—Reply
Thomas D. Bird, MD; Chang-En Yu, PhD
Arch Neurol. 2011;68(9):1210-1211. doi:10.1001/archneurol.2011.219.
Neurological Review |  September 01, 2011 FREE
Rapidly Progressive Alzheimer Disease
Christian Schmidt, MD; Martin Wolff, MD; Michael Weitz, MD; et al.
Arch Neurol. 2011;68(9):1124-1130. doi:10.1001/archneurol.2011.189.
Original Contributions |  September 01, 2011
Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
Anne M. Fagan, PhD; Leslie M. Shaw, PhD; Chengjie Xiong, PhD; et al.
Arch Neurol. 2011;68(9):1137-1144. doi:10.1001/archneurol.2011.105.
INCLUDES: CME
Special Article |  September 01, 2011
Risk Factors and Preventive Interventions for Alzheimer Disease:  State of the Science
Martha L. Daviglus, MD, PhD; Brenda L. Plassman, PhD; Amber Pirzada, MD; et al.
Arch Neurol. 2011;68(9):1185-1190. doi:10.1001/archneurol.2011.100.
Commentary in Neurology |  August 01, 2011
Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
Bradley T. Hyman, MD, PhD
Arch Neurol. 2011;68(8):1062-1064. doi:10.1001/archneurol.2011.70.
Clinical Trials |  August 01, 2011 FREE
Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
Lon S. Schneider, MD, MS; Karen S. Dagerman, MS; Julian P. T. Higgins, PhD; et al.
Arch Neurol. 2011;68(8):991-998. doi:10.1001/archneurol.2011.69.
Original Contributions |  August 01, 2011
The Dynamics of Cortical and Hippocampal Atrophy in Alzheimer Disease
Mert R. Sabuncu, PhD; Rahul S. Desikan, MD, PhD; Jorge Sepulcre, MD, PhD; et al.
Arch Neurol. 2011;68(8):1040-1048. doi:10.1001/archneurol.2011.167.
Original Contributions |  August 01, 2011
Ecology of the Aging Human Brain
Joshua A. Sonnen, MD; Karen Santa Cruz, MD; Laura S. Hemmy, PhD; et al.
Arch Neurol. 2011;68(8):1049-1056. doi:10.1001/archneurol.2011.157.
Original Contributions |  August 01, 2011
Association and Expression Analyses With Single-Nucleotide Polymorphisms in TOMM40 in Alzheimer Disease
Carlos Cruchaga, PhD; Petra Nowotny, PhD; John S. K. Kauwe, PhD; et al.
Arch Neurol. 2011;68(8):1013-1019. doi:10.1001/archneurol.2011.155.
Original Contributions |  July 01, 2011
In Vivo Assessment of Vesicular Monoamine Transporter Type 2 in Dementia With Lewy Bodies and Alzheimer Disease
Victor L. Villemagne, MD; Nobuyuki Okamura, MD; Svetlana Pejoska, RN; et al.
Arch Neurol. 2011;68(7):905-912. doi:10.1001/archneurol.2011.142.
Commentary in Neurology |  June 01, 2011
Stroke and Alzheimer Disease:  Fellow Travelers or Partners in Crime?
Vladimir Hachinski, MD, DSc
Arch Neurol. 2011;68(6):797-798. doi:10.1001/archneurol.2011.118.
Correspondence |  May 01, 2011
Blood-Based Biomarkers in Alzheimer Disease—Reply
Sid E. O’Bryant, PhD
Arch Neurol. 2011;68(5):685-686. doi:10.1001/archneurol.2011.79.
Correspondence |  May 01, 2011
Blood-Based Biomarkers in Alzheimer Disease
Christoph Laske, MD
Arch Neurol. 2011;68(5):685-686. doi:10.1001/archneurol.2011.78.
Correspondence |  April 01, 2011
Targets of the Peroxisome Proliferator–Activated Receptor γ Agonist Trials for the Prevention of Alzheimer Disease
Takashi Sakurai, MD, PhD
Arch Neurol. 2011;68(4):542-543. doi:10.1001/archneurol.2011.57.
Correspondence |  April 01, 2011
Targets of the Peroxisome Proliferator–Activated Receptor γ Agonist Trials for the Prevention of Alzheimer Disease—Reply
David S. Geldmacher, MD; Thomas Fritsch, PhD; Gary E. Landreth, PhD
Arch Neurol. 2011;68(4):542-543. doi:10.1001/archneurol.2011.58.
Original Contribution |  March 01, 2011 FREE
The Structured Interview & Scoring Tool–Massachusetts Alzheimer's Disease Research Center (SIST-M):  Development, Reliability, and Cross-Sectional Validation of a Brief Structured Clinical Dementia Rating Interview
Olivia I. Okereke, MD, SM; Maura Copeland, MD; Bradley T. Hyman, MD, PhD; et al.
Arch Neurol. 2011;68(3):343-350. doi:10.1001/archneurol.2010.375.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Invited Commentary  |  April 15, 2013
Exercise in Alzheimer Disease :  Comment on “Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX): A Randomized Controlled Trial”
A. Mark Clarfield, MD, FRCPC; Tzvi Dwolatzky, MD, MBBCh
JAMA Internal Medicine
Original Investigation  |  April 15, 2013
Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX):  A Randomized Controlled Trial
Kaisu H. Pitkälä, MD, PhD; Minna M. Pöysti, MD, PhD; Marja-Liisa Laakkonen, MD, PhD; et al.
JAMA
News From the Centers for Disease Control and Prevention  |  May 01, 2013
Alzheimer Deaths Increased During the Previous Decade
JAMA
Editorial  |  April 10, 2013
Genome-Wide Association Studies, Alzheimer Disease, and Understudied Populations
Robert L. Nussbaum, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems